Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSemaglutide (Wegovy) can affect the mouth in several ways, including dryness, altered taste and occasional ulcers. These effects are real, documented in clinical data, and worth understanding before you start treatment. They are not a sign something has gone badly wrong, but they do deserve a clear explanation. As a prescription-only medicine, Wegovy is available only after a clinical assessment confirms it is right for you personally.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The STEP 1 phase-3 trial, published in the New England Journal of Medicine, enrolled nearly 2,000 adults with obesity and tracked them for 68 weeks on semaglutide 2.4mg. The most frequently reported side effects were gastrointestinal: nausea, diarrhoea, vomiting and constipation accounted for the vast majority of adverse events. Mouth-specific symptoms were not among the headline findings, but they sit within a broader pattern: when the gut slows down and saliva production is disrupted by reduced food intake and frequent nausea, the mouth bears some of the consequences.
The NHS medicines page for semaglutide lists dry mouth as an uncommon side effect — meaning it affects fewer than 1 in 10 people but more than 1 in 100. That places it in the same category as burping and heartburn: not unusual enough to be remarkable, not common enough to be guaranteed. If you search online for whether Wegovy causes dry mouth, you will find plenty of people who have experienced it; the frequency just tends to be under-reported in official summaries because it is rarely severe.
Taste changes follow a similar pattern. Semaglutide alters appetite signalling in the brain and slows the rate at which food moves through the stomach. Both of these changes can dull or shift how flavours register. Some people find sweet foods taste less appealing; others notice a metallic or slightly bitter background. The effect is usually partial and temporary, though it may last for several weeks after a dose increase.
Saliva production is partly governed by eating behaviour. When Wegovy reduces hunger and you eat smaller, less frequent meals, less chewing and less food stimulation means less saliva. Nausea compounds this: if you are sipping rather than drinking freely to avoid triggering sickness, mild dehydration sets in, and the mouth dries out. That is the mechanism behind most cases of Wegovy-related dry mouth.
The practical fixes are straightforward, if not always easy to maintain. Sipping plain water consistently across the day helps more than drinking large amounts in one go. Sugar-free chewing gum stimulates saliva without adding anything that would irritate an already-sensitive stomach. Alcohol and caffeine both worsen dehydration, so cutting back during dose-increase weeks is worth trying. Breathing through the nose rather than the mouth sounds simple, but mouth-breathing accelerates drying.
It is worth knowing that dry mouth linked to Wegovy rarely requires stopping treatment. In most cases, the symptom peaks in the first two to four weeks on a new dose and then settles. If it persists or feels severe, it should be raised with your prescriber at the next check-in, not managed in silence.
For context on what the wider treatment involves, including how doses are structured and what clinical monitoring looks like, the Wegovy overview on this site covers the full picture.
A Wegovy mouth ulcer is less common than dry mouth but follows recognisable logic. Dehydration dries the mucosal lining; minor abrasions from food heal more slowly when saliva is scarce; and stress on the immune system during early treatment can temporarily reduce resistance to the kind of minor infections that produce ulcers. None of that means Wegovy is causing tissue damage. It means conditions in the mouth become slightly less favourable for a period.
A persistent bad or metallic taste is reported less often than dryness, but it does appear in patient accounts and is consistent with the altered digestive rhythm. Gastric acid that lingers longer in the oesophagus (a recognised GLP-1 class effect) can contribute a sour or bitter note. Gentle antacids, eating smaller amounts more slowly, and avoiding lying flat for at least an hour after eating all reduce reflux and, with it, the taste disruption.
If mouth ulcers are large, fail to heal within two weeks, appear repeatedly, or are accompanied by fever, see your GP or dentist. That advice applies regardless of whether you are on Wegovy; it is the standard threshold for investigating a mouth ulcer. For everything below that threshold, standard over-the-counter gels and good hydration are appropriate first steps, and your prescriber should know about it at your next review.
Mouth symptoms, when they do arise, are one small part of a treatment that the STEP 1 trial showed to reduce body weight by around 15% on average over 68 weeks in people with obesity. For most people, the side-effect profile is manageable; the gastrointestinal effects, including those that touch the mouth, typically ease over time. The licensed route to Wegovy in the UK is a prescription from a qualified prescriber, following an assessment of your health history and current circumstances. There is no shortcut around that step, and nor should there be.
If you are trying to understand whether Wegovy is right for you, the semaglutide information page gives a grounded, clinically accurate overview. For those weighing up different treatment options (including the range of licensed weight-loss treatments available in the UK) a full consultation is the right place to start. You can also read more about how our clinical team approaches prescribing on the prescriber profile page. Questions about cost? That sits on a separate page; you can find what to expect when accessing Wegovy privately there. When you are ready to take the next step, start your free consultation and a GPhC-registered prescriber, not an algorithm, will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.